PALB2 c.2205A>G ;(p.P735=)

Variant ID: 16-23641270-T-C

NM_024675.3(PALB2):c.2205A>G;(p.P735=)

This variant was identified in 3 publications

View GRCh38 version.




Publications:


Identification of targeted therapy options for gastric adenocarcinoma by comprehensive analysis of genomic data.

Gastric Cancer : Official Journal Of The International Gastric Cancer Association And The Japanese Gastric Cancer Association
Hescheler, Daniel A DA; Plum, Patrick S PS; Zander, Thomas T; Quaas, Alexander A; Korenkov, Michael M; Gassa, Asmae A; Michel, Maximilian M; Bruns, Christiane J CJ; Alakus, Hakan H
Publication Date: 2020-07

Variant appearance in text: PALB2: P735P
PubMed Link: 32107691
Variant Present in the following documents:
  • 10120_2020_1045_MOESM1_ESM.xlsx, sheet 2
View BVdb publication page



A pan-cancer analysis of synonymous mutations.

Nature Communications
Sharma, Yogita Y; Miladi, Milad M; Dukare, Sandeep S; Boulay, Karine K; Caudron-Herger, Maiwen M; Groß, Matthias M; Backofen, Rolf R; Diederichs, Sven S
Publication Date: 2019-06-12

Variant appearance in text: PALB2: 2205A>G
PubMed Link: 31189880
Variant Present in the following documents:
  • 41467_2019_10489_MOESM7_ESM.xlsx, sheet 1
  • 41467_2019_10489_MOESM5_ESM.xlsx, sheet 1
View BVdb publication page



Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals.

Breast Cancer Research : Bcr
Kuusisto, Kirsi M KM; Bebel, Aleksandra A; Vihinen, Mauno M; Schleutker, Johanna J; Sallinen, Satu-Leena SL
Publication Date: 2011-02-28

Variant appearance in text: PALB2: 2205A>G; Pro735Pro
PubMed Link: 21356067
Variant Present in the following documents:
  • Main text
  • bcr2832.pdf
View BVdb publication page